tirzepatide injection for weight loss is a New Medication Diabetes and Tirzepatide and other weight-loss medications

MTHFR gene mutation is a common genetic variation that can impact folate metabolism and increase the risk of certain health conditions.

Adults with overweight or obesity who took semaglutide demonstrated short- and longer-term improvements in controlling their eating habits and substantial weight loss, according to the latest findings from the Semaglutide Treatment Effect in People with obesity (STEP) 5 trial

By improving insulin sensitivity and slowing gastric emptying, tirzepatide helps the body better manage glucose levels while promoting feelings of fullness that can support sustainable weight loss

GLP-1 muscle loss is real

The highest approved dose of oral semaglutide (14 mg) reduced glycated hemoglobin significantly more than placebo, empagliflozin, dulaglutide, and sitagliptin, and was non-inferior to liraglutide

Book a consultation for a personalized, physician-supervised weight loss plan.